Thesis: Thesis Raises Another $8.4M to Improve your Cognitive Performance Based on Your Body's Brain Chemistry

The use of nootropics, chemical or natural substances that have a positive impact on mental skills, is an emerging field in neuropsychology. The most common nootropic in use today is caffeine, which has been proven to improve thinking skills as caffeine has an impact on neurotransmitters in your brain that helps with short-term memory and learning. Nootropics are also becoming popular beyond caffeine as supplements are being developed to help with mental acuity. Thesis is a supplement brand that's focused on improving cognitive performance by focusing on your individual chemistry as well as your specific goals. Most nootropics brands offer a one-size fits all approach to their offerings; Thesis instead takes a personalized approach, using the first month to understand what works best for a specific person and then formulates the ingredients based on specific factors. This initial assessment can be done for only $79, while other offerings could take you six months and cost ten times that. Offering formulations for energy, creativity, logic, clarity, confidence, and motivation, Thesis has helped over half a million customers since 2017. All nutrients used are vegan, offer high bioavailability (absorbed efficiently), and are rigorously tested for purity. AlleyWatch caught up with Thesis CEO and Founder Dan Freed to learn more about the business, the company's strategic plans, latest round of funding, which brings the company's total funding raised to $13.5M, and much, much more...